Clinical Trials in Ohio

Showing 2821-2840 of 17,983 trials

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

NCT03573310

The purpose of the study is to identify the maximum tolerated dose (MTD) of JNJ-64619178 in participants with relapsed/refractory B cell non-Hodgkin lymphoma (NHL) or advanced solid tumors and also to identify the recommended Phase 2 dose(s) (RP2Ds) of JNJ-64619178 for NHL and advanced solid tumors (Part 1) and to confirm the tolerability of JNJ-64619178 in participants with lower risk myelodysplastic syndromes (MDS) (Part 2).

NeoplasmsSolid Tumor, AdultNon-Hodgkin Lymphoma+1 more

Janssen Research & Development, LLC114 participantsStarted Jul 2018

Sarasota, Florida, United States • Boston, Massachusetts, United States • Columbus, Ohio, United States +15 more locations

Active Not RecruitingPhase 432 miles

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

NCT06571383

The study is testing how well semaglutide can help adolescents with excess body weight to lose weight and to maintain weight loss. All participants in the study will receive semaglutide as a weekly injection. The study medicine is injected with a thin needle in the stomach, thighs or upper arms. All participants will get semaglutide treatment for a minimum of 3 years.

Obesity

Novo Nordisk A/S500 participantsStarted Sep 2024

Escondido, California, United States • Orlando, Florida, United States • Tallahassee, Florida, United States +90 more locations

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

Find Trials by Condition in Ohio

Inspiratory Muscle Training Immediately After Lung Transplantation

Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

SyncAV Post-Market Trial

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine

Multisite Virtual Reality Intervention for Speech Anxiety

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Study of Aspirin in Patients With Vestibular Schwannoma

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID